SERA Sera Prognostics, Inc.
Healthcare$2.15+3.86%ClosedMarket Cap: $82.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.60
P/S
1440.54
EV/EBITDA
-2.48
DCF Value
$-0.02
FCF Yield
-33.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-191.2%
Operating Margin
-64235.1%
Net Margin
-56386.0%
ROE
-41.0%
ROA
-34.4%
ROIC
-52.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $14.0K | -200.0% | $-9.4M | $-8.4M | $— | — |
| Q4 null | $10.0K | -320.0% | $-9.0M | $-7.9M | $— | — |
| FY null | $81.0K | -102.5% | $-36.5M | $-31.9M | $— | — |
| Q3 null | $16.0K | -156.3% | $-9.0M | $-7.8M | $— | — |
| Q2 null | $17.0K | -141.2% | $-9.3M | $-8.0M | $— | — |
| Q1 null | $38.0K | -5.3% | $-9.3M | $-8.2M | $— | — |
| Q4 null | $24.0K | -33.3% | $-9.4M | $-8.6M | $— | — |
| FY null | $77.0K | -6.5% | $-36.6M | $-32.9M | $— | — |
| Q3 null | $29.0K | 55.2% | $-8.9M | $-7.9M | $— | — |
| Q2 null | $24.0K | 16.7% | $-9.3M | $-8.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-9.1M | $-8.1M | $— | — |
| Q4 2023 | $41.0K | -475.6% | $-8.7M | $-7.9M | $-0.25 | — |